Table of Content

1 Market Overview
1.1 Oncology Injection Drug Introduction
1.2 Market Analysis by Types
1.3 Market Analysis by Applications
1.4 Global Oncology Injection Drug Market Size & Forecast
1.4.1 Global Oncology Injection Drug Revenue (2018 VS 2022 VS 2029)
1.4.2 Global Oncology Injection Drug Revenue in Value (2018-2029)
1.5 Market Drivers, Restraints and Trends
1.5.1 Oncology Injection Drug Market Drivers
1.5.2 Oncology Injection Drug Market Restraints
1.5.3 Oncology Injection Drug Trends Analysis
1.6 Economic Analysis of Global Regions
1.7 Inflation Analysis
1.8 The Impact of the Russian-Ukrainian War on the Market
1.9 Coronavirus Disease 2020 (COVID-19) Impact on Global
2 Manufacturers Profiles
2.1 Taj Oncology
2.1.1 Business Overview
2.1.2 Taj Oncology SWOT Analysis
2.1.3 Taj Oncology Oncology Injection Drug Products and Service Offered
2.1.4 Taj Oncology Oncology Injection Drug Revenue and Gross Margin
2.2 S.G. Biopharm
2.2.1 Business Overview
2.2.2 S.G. Biopharm SWOT Analysis
2.2.3 S.G. Biopharm Oncology Injection Drug Products and Service Offered
2.2.4 S.G. Biopharm Oncology Injection Drug Revenue and Gross Margin
2.3 AdvaCare
2.3.1 Business Overview
2.3.2 AdvaCare SWOT Analysis
2.3.3 AdvaCare Oncology Injection Drug Products and Service Offered
2.3.4 AdvaCare Oncology Injection Drug Revenue and Gross Margin
2.4 Merrimack
2.4.1 Business Overview
2.4.2 Merrimack SWOT Analysis
2.4.3 Merrimack Oncology Injection Drug Products and Service Offered
2.4.4 Merrimack Oncology Injection Drug Revenue and Gross Margin
2.5 Celgene
2.5.1 Business Overview
2.5.2 Celgene SWOT Analysis
2.5.3 Celgene Oncology Injection Drug Products and Service Offered
2.5.4 Celgene Oncology Injection Drug Revenue and Gross Margin
2.6 Allos Therapeutics
2.6.1 Business Overview
2.6.2 Allos Therapeutics SWOT Analysis
2.6.3 Allos Therapeutics Oncology Injection Drug Products and Service Offered
2.6.4 Allos Therapeutics Oncology Injection Drug Revenue and Gross Margin
2.7 Ferring Pharmaceuticals
2.7.1 Business Overview
2.7.2 Ferring Pharmaceuticals SWOT Analysis
2.7.3 Ferring Pharmaceuticals Oncology Injection Drug Products and Service Offered
2.7.4 Ferring Pharmaceuticals Oncology Injection Drug Revenue and Gross Margin
2.8 Genzyme
2.8.1 Business Overview
2.8.2 Genzyme SWOT Analysis
2.8.3 Genzyme Oncology Injection Drug Products and Service Offered
2.8.4 Genzyme Oncology Injection Drug Revenue and Gross Margin
2.9 Eli Lilly
2.9.1 Business Overview
2.9.2 Eli Lilly SWOT Analysis
2.9.3 Eli Lilly Oncology Injection Drug Products and Service Offered
2.9.4 Eli Lilly Oncology Injection Drug Revenue and Gross Margin
2.10 Praecis Pharmaceuticals
2.10.1 Business Overview
2.10.2 Praecis Pharmaceuticals SWOT Analysis
2.10.3 Praecis Pharmaceuticals Oncology Injection Drug Products and Service Offered
2.10.4 Praecis Pharmaceuticals Oncology Injection Drug Revenue and Gross Margin
2.11 Millennium Pharmaceuticals
2.11.1 Business Overview
2.11.2 Millennium Pharmaceuticals SWOT Analysis
2.11.3 Millennium Pharmaceuticals Oncology Injection Drug Products and Service Offered
2.11.4 Millennium Pharmaceuticals Oncology Injection Drug Revenue and Gross Margin
2.12 Debiopharm
2.12.1 Business Overview
2.12.2 Debiopharm SWOT Analysis
2.12.3 Debiopharm Oncology Injection Drug Products and Service Offered
2.12.4 Debiopharm Oncology Injection Drug Revenue and Gross Margin
2.13 Alza
2.13.1 Business Overview
2.13.2 Alza SWOT Analysis
2.13.3 Alza Oncology Injection Drug Products and Service Offered
2.13.4 Alza Oncology Injection Drug Revenue and Gross Margin
2.14 CordenPharma
2.14.1 Business Overview
2.14.2 CordenPharma SWOT Analysis
2.14.3 CordenPharma Oncology Injection Drug Products and Service Offered
2.14.4 CordenPharma Oncology Injection Drug Revenue and Gross Margin
2.15 Pharmascience
2.15.1 Business Overview
2.15.2 Pharmascience SWOT Analysis
2.15.3 Pharmascience Oncology Injection Drug Products and Service Offered
2.15.4 Pharmascience Oncology Injection Drug Revenue and Gross Margin
3 Global Oncology Injection Drug Market Competition, by Manufacturer
3.1 Global Oncology Injection Drug Revenue and Market Share by Manufacturer
3.2 Market Concentration Rate
3.2.1 Top 3 Oncology Injection Drug Players Market Share in 2022
3.2.2 Top 6 Oncology Injection Drug Players Market Share in 2022
3.2.3 Market Competition Trend
3.3 Oncology Injection Drug Players Head Office, Business Provided
3.4 Oncology Injection Drug Mergers & Acquisitions
3.5 Oncology Injection Drug New Entrants and Expansion Plans
4 Market Segment by Type
4.1 Global Oncology Injection Drug Revenue in Value by Type (2018-2029)
4.2 Global Oncology Injection Drug Revenue Share by Type (2018-2029)
5 Market Segment by Application
5.1 Global Oncology Injection Drug Revenue by Application (2018-2029)
5.2 Global Oncology Injection Drug Revenue Share by Application (2018-2029)
6 Global Oncology Injection Drug Market Analysis by Regions
6.1 Global Oncology Injection Drug Revenue and Market Share by Regions
6.1.1 Global Oncology Injection Drug Revenue by Regions (2018-2029)
6.1.2 Global Oncology Injection Drug Revenue Market Share by Regions (2018-2029)
6.2 North America Oncology Injection Drug Revenue and Growth (2018-2029)
6.3 Europe Oncology Injection Drug Revenue and Growth (2018-2029)
6.4 Asia Pacific Oncology Injection Drug Revenue and Growth (2018-2029)
6.5 South America Oncology Injection Drug Revenue and Growth (2018-2029)
6.6 Middle East and Africa Oncology Injection Drug Revenue and Growth (2018-2029)
7 North America Oncology Injection Drug by Country, by Type, and by Application
7.1 North America Oncology Injection Drug Revenue by Type (2018-2029)
7.2 North America Oncology Injection Drug Revenue by Application (2018-2029)
7.3 North America Oncology Injection Drug Revenue and Market Share by Countries
7.3.1 North America Oncology Injection Drug Revenue in Value by Country (2018-2029)
7.3.2 United States Oncology Injection Drug Revenue and Growth (2018-2029)
7.3.3 Canada Oncology Injection Drug Revenue and Growth (2018-2029)
7.3.4 Mexico Oncology Injection Drug Revenue and Growth (2018-2029)
7.4 North America SWOT Analysis
8 Europe Oncology Injection Drug by Country, by Type, and by Application
8.1 Europe Oncology Injection Drug Revenue by Type (2018-2029)
8.2 Europe Oncology Injection Drug Revenue by Application (2018-2029)
8.3 Europe Oncology Injection Drug Revenue and Market Share by Countries
8.3.1 Europe Oncology Injection Drug Revenue in Value by Country (2018-2029)
8.3.2 Germany Oncology Injection Drug Revenue and Growth (2018-2029)
8.3.3 France Oncology Injection Drug Revenue and Growth (2018-2029)
8.3.4 United Kingdom Oncology Injection Drug Revenue and Growth (2018-2029)
8.3.5 Russia Oncology Injection Drug Revenue and Growth (2018-2029)
8.3.6 Italy Oncology Injection Drug Revenue and Growth (2018-2029)
8.3.7 Nordic Oncology Injection Drug Revenue and Growth (2018-2029)
8.4 Europe SWOT Analysis
9 Asia Pacific Oncology Injection Drug by Country, by Type, and by Application
9.1 Asia Pacific Oncology Injection Drug Revenue by Type (2018-2029)
9.2 Asia Pacific Oncology Injection Drug Revenue by Application (2018-2029)
9.3 Asia Pacific Oncology Injection Drug Revenue and Market Share by Countries
9.3.1 Asia Pacific Oncology Injection Drug Revenue in Value by Country (2018-2029)
9.3.2 China Oncology Injection Drug Revenue and Growth (2018-2029)
9.3.3 Japan Oncology Injection Drug Revenue and Growth (2018-2029)
9.3.4 Korea Oncology Injection Drug Revenue and Growth (2018-2029)
9.3.5 India Oncology Injection Drug Revenue and Growth (2018-2029)
9.3.6 Southeast Asia Oncology Injection Drug Revenue and Growth (2018-2029)
9.3.7 Australia Oncology Injection Drug Revenue and Growth (2018-2029)
9.4 Asia Pacific SWOT Analysis
10 South America Oncology Injection Drug by Country, by Type, and by Application
10.1 South America Oncology Injection Drug Revenue by Type (2018-2029)
10.2 South America Oncology Injection Drug Revenue by Application (2018-2029)
10.3 South America Oncology Injection Drug Revenue and Market Share by Countries
10.3.1 South America Oncology Injection Drug Revenue in Value by Country (2018-2029)
10.3.2 Brazil Oncology Injection Drug Revenue and Growth (2018-2029)
10.3.3 Argentina Oncology Injection Drug Revenue and Growth (2018-2029)
10.4 South America SWOT Analysis
11 Middle East & Africa Oncology Injection Drug by Country, by Type, and by Application
11.1 Middle East & Africa Oncology Injection Drug Revenue by Type (2018-2029)
11.2 Middle East & Africa Oncology Injection Drug Revenue by Application (2018-2029)
11.3 Middle East & Africa Oncology Injection Drug Revenue and Market Share by Countries
11.3.1 Middle East & Africa Oncology Injection Drug Revenue in Value by Country (2018-2029)
11.3.2 Turkey Oncology Injection Drug Revenue and Growth (2018-2029)
11.3.3 Egypt Oncology Injection Drug Revenue and Growth (2018-2029)
11.3.4 Saudi Arabia Oncology Injection Drug Revenue and Growth (2018-2029)
11.3.5 UAE Oncology Injection Drug Revenue and Growth (2018-2029)
11.3.6 South Africa Oncology Injection Drug Revenue and Growth (2018-2029)
11.4 Middle East and Africa SWOT Analysis
12 Oncology Injection Drug Business Cost Analysis
12.1 Proportion of Business Cost Structure
12.1.1 Labor Cost
12.1.2 Operating Expenses
12.2 Oncology Injection Drug Industrial Chain Analysis
13 Research Findings and Conclusion
14 Methodology and Data Source
14.1 A Methodology
14.1.1 Research Process
14.1.2 Market Size Estimation
14.1.3 Market Breakdown and Data Triangulation
14.2 B Data Source
14.2.1 Legal Disclaimer